IMOVAX d.T. adult, suspension for injection in prefilled syringe. Adsorbed diphtheria and tetanus vaccine. Malta - English - Medicines Authority

imovax d.t. adult, suspension for injection in prefilled syringe. adsorbed diphtheria and tetanus vaccine.

sanofi pasteur 14 espace henry vallée , 69007 lyon, france - diphtheria toxoid, tetanus toxoid - suspension for injection - diphtheria toxoid tetanus toxoid - vaccines

TRIAXIS Unknown Suspension for Injection Ireland - English - HPRA (Health Products Regulatory Authority)

triaxis unknown suspension for injection

sanofi pasteur - tetanus toxoid, diphtheria toxoid, pertussis toxoid, filamentous haemagglutinin, pertactin, fimbriae types 2 and 3, adsorbed aluminium phosphate - suspension for injection - unknown - pertussis, purified antigen, combinations with toxoids

Triaxis, suspension for injection in a pre-filled syringeDiphtheria, Tetanus, Pertussis (acellular component) Vaccine (adsorbed, reduced antigen(s) content) Ireland - English - HPRA (Health Products Regulatory Authority)

triaxis, suspension for injection in a pre-filled syringediphtheria, tetanus, pertussis (acellular component) vaccine (adsorbed, reduced antigen(s) content)

sanofi pasteur - diphtheria toxoid; tetanus toxoid; pertussis toxoid; filamentous haemagglutinin; pertactin (prn); fimbriae types 2 and 3 - suspension for injection in pre-filled syringe - 0 international unit(s) - pertussis vaccines; pertussis, purified antigen, combinations with toxoids

FLUZONE QUADRIVALENT SOUTHERN HEMISPHERE (influenza a virus a/brisbane/02/2018 ivr-190 (h1n1) antigen (formaldehyde inactivated) United States - English - NLM (National Library of Medicine)

fluzone quadrivalent southern hemisphere (influenza a virus a/brisbane/02/2018 ivr-190 (h1n1) antigen (formaldehyde inactivated)

sanofi pasteur inc. - influenza a virus a/brisbane/02/2018 ivr-190 (h1n1) antigen (formaldehyde inactivated) (unii: xw4jb03ti5) (influenza a virus a/brisbane/02/2018 ivr-190 (h1n1) hemagglutinin antigen (formaldehyde inactivated) - unii:92xe6ghc89), influenza a virus a/south australia/34/2019 ivr-197 (h3n2) antigen (formaldehyde inactivated) (unii: 9g0xu62hkp) (influenza a virus a/south australia/34/2019 ivr-197 (h3n2) hemagglutinin antigen (formaldehyde inactivated) - unii:nd5y3fdi9p), influenza b virus b/phuket/3073/2013 ant - fluzone® quadrivalent southern hemisphere is a vaccine indicated for active immunization for the prevention of influenza disease caused by influenza a subtype viruses and type b viruses contained in the vaccine. fluzone quadrivalent southern hemisphere is approved for use in persons 6 months of age and older. do not administer fluzone quadrivalent southern hemisphere to anyone with a history of a severe allergic reaction (e.g., anaphylaxis) to any component of the vaccine [see description (11) ], including egg protein, or to a previous dose of any influenza vaccine. fluzone quadrivalent southern hemisphere and fluzone quadrivalent are manufactured using the same process. data in this section were obtained in studies with fluzone quadrivalent. pregnancy exposure registry sanofi pasteur inc. is maintaining a prospective pregnancy exposure registry to collect data on pregnancy outcomes following vaccination with fluzone quadrivalent during pregnancy. healthcare providers are encouraged to enroll women who rece

Vaxigrip suspension for injection in prefilled syringe.Influenza vaccine (split virion, inactivated) Malta - English - Medicines Authority

vaxigrip suspension for injection in prefilled syringe.influenza vaccine (split virion, inactivated)

sanofi pasteur 14 espace henry vallée , 69007 lyon, france - influenza vaccine, split virion, inactivated - suspension for injection - influenza vaccine (split virion, inactivated) 15 µg - vaccines

REPEVAX, suspension for injection, in pre-filled syringe Diphtheria, Tetanus, Pertussis (acellular, component) and Poliomyelitis (inactivated) Vaccine (adsorbed, reduced antigen(s) content) Ireland - English - HPRA (Health Products Regulatory Authority)

repevax, suspension for injection, in pre-filled syringe diphtheria, tetanus, pertussis (acellular, component) and poliomyelitis (inactivated) vaccine (adsorbed, reduced antigen(s) content)

sanofi pasteur - tetanus toxoid; diphtheria toxoid; pertussis toxoid; filamentous haemagglutinin (fha); pertactin; polio virus type 1 inactivated; polio virus type 2 inactivated; polio virus type 3 inactivated; adsorbed aluminium phosphate; adsorbed fimbriae types 2 + 3 - suspension for injection in pre-filled syringe - 0.5 millilitre(s) - bacterial and viral vaccines, combined; diphtheria-pertussis-poliomyelitis-tetanus

ACT-HIB 10mcg/0.5m Microgram/ML Pdr+Solv for Soln for Inj Ireland - English - HPRA (Health Products Regulatory Authority)

act-hib 10mcg/0.5m microgram/ml pdr+solv for soln for inj

sanofi pasteur msd ltd - haemophilus influenzae type b, conjugate with tetanus protein - pdr+solv for soln for inj - 10mcg/0.5m microgram/ml - hemophilus influenzae b vaccines

PNEUMOVAX 25mcg/0.5m %v/v Solution for Injection Ireland - English - HPRA (Health Products Regulatory Authority)

pneumovax 25mcg/0.5m %v/v solution for injection

sanofi pasteur msd ltd - pneumococcal vaccine - solution for injection - 25mcg/0.5m %v/v - pneumococcal vaccines

POLIOMYELITIS VACCINE %v/v Suspension for Injection Ireland - English - HPRA (Health Products Regulatory Authority)

poliomyelitis vaccine %v/v suspension for injection

sanofi pasteur msd ltd - polio virus type 1 inactivated, polio virus type 2 inactivated, polio virus type 3 inactivated - suspension for injection - %v/v - poliomyelitis vaccines

VARIVAX > 1350 PFU Pdr+Solv for Susp for Inj Ireland - English - HPRA (Health Products Regulatory Authority)

varivax > 1350 pfu pdr+solv for susp for inj

sanofi pasteur msd ltd - varicella virus (oka strain) live attenuated - pdr+solv for susp for inj - > 1350 pfu - varicella zoster vaccines